TCON insider filings

Tracon Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-03-13. Screen TCON transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TCON between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Tracon Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2024-03-134Brown Scott B. — CHIEF FINANCIAL OFFICERGrant/award (A): 3,500 @ $0.14 · Grant/award (A): 224,800 (derivative) @ $0EDGAR
2024-03-134THEUER CHARLES — PRESIDENT AND CEO, DirectorGrant/award (A): 3,500 @ $0.14 · Grant/award (A): 3,500 @ $0.13 · Grant/award (A): 518,300 (derivative) @ $0EDGAR
2023-11-144Opaleye Management Inc. — 10% ownerSale (S): 4,324,008 @ $0.29 · Sale (S): 440,000 @ $0.29EDGAR
2023-04-284THEUER CHARLES — President and CEO, DirectorPurchase (P): 3,999 @ $0.66 · Purchase (P): 47,000 @ $0.75EDGAR
2023-04-214Johnson-Pratt Lisa — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-04-214Lam Carol C. — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-04-214Twiford J Rainer — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-04-214WORLAND STEPHEN T — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-04-214LARUE WILLIAM R — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-04-214MATTINGLY MARTIN A — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-04-214PELLETIER SAUNDRA L — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-03-134Opaleye Management Inc. — 10% ownerPurchase (P): 174,508 @ $1.38EDGAR
2023-03-024THEUER CHARLES — President and CEO, DirectorPurchase (P): 200 @ $1.52 · Purchase (P): 4,800 @ $1.52EDGAR
2023-02-094Adams Bonne J. — Chief Operating OfficerGrant/award (A): 99,000 (derivative) @ $0EDGAR
2023-02-034Brown Scott B. — Chief Financial OfficerGrant/award (A): 144,000 (derivative) @ $0EDGAR
2023-02-034THEUER CHARLES — President and CEO, DirectorGrant/award (A): 332,000 (derivative) @ $0EDGAR
2023-01-194THEUER CHARLES — President and CEO, DirectorPurchase (P): 6,800 @ $1.62EDGAR
2023-01-194LARUE WILLIAM R — DirectorSale (S): 120 @ $1.26EDGAR
2023-01-034Brown Scott B. — Chief Financial OfficerPurchase (P): 3,500 @ $1.49EDGAR
2022-12-164Opaleye Management Inc. — 10% ownerPurchase (P): 140,000 @ $1.26 · Purchase (P): 27,500 @ $1.24EDGAR
2022-12-154THEUER CHARLES — President and CEO, DirectorPurchase (P): 23,000 @ $1.29EDGAR
2022-12-084Opaleye Management Inc. — 10% ownerOption exercise/expiry (X): 221,539 @ $0.01 · Sale (S): 1,539 @ $1.44 · Option exercise/expiry (X): 221,539 (derivative) @ $0.01EDGAR
2022-11-224THEUER CHARLES — President and CEO, DirectorPurchase (P): 13,900 @ $1.41EDGAR
2022-11-044THEUER CHARLES — President and CEO, DirectorPurchase (P): 9,200 @ $1.52EDGAR
2022-11-034THEUER CHARLES — President and CEO, DirectorPurchase (P): 6,000 @ $1.59EDGAR
2022-10-194Opaleye Management Inc. — 10% ownerPurchase (P): 10,000 @ $1.65 · Purchase (P): 2,500 @ $1.65EDGAR
2022-10-114THEUER CHARLES — President and CEO, DirectorPurchase (P): 5,000 @ $1.77EDGAR
2022-10-054THEUER CHARLES — President and CEO, DirectorPurchase (P): 5,000 @ $1.67EDGAR
2022-10-034Opaleye Management Inc. — 10% ownerPurchase (P): 9,400 @ $1.74EDGAR
2022-09-284Opaleye Management Inc. — 10% ownerPurchase (P): 1,700 @ $1.69EDGAR
2022-09-264THEUER CHARLES — President and CEO, DirectorPurchase (P): 5,000 @ $1.76EDGAR
2022-09-224Opaleye Management Inc. — 10% ownerPurchase (P): 3,411 @ $1.73 · Purchase (P): 13,900 @ $1.73EDGAR
2022-09-204Opaleye Management Inc. — 10% ownerPurchase (P): 10,000 @ $1.85EDGAR
2022-09-194Opaleye Management Inc. — 10% ownerPurchase (P): 5,000 @ $1.87EDGAR
2022-09-144Brown Scott B. — Chief Financial OfficerPurchase (P): 2,500 @ $2.02EDGAR
2022-07-264Opaleye Management Inc. — 10% ownerPurchase (P): 2,254 @ $1.72EDGAR
2022-07-254THEUER CHARLES — President and CEO, DirectorPurchase (P): 4,500 @ $1.85EDGAR
2022-07-154Opaleye Management Inc. — 10% ownerPurchase (P): 11,826 @ $1.78EDGAR
2022-07-144Opaleye Management Inc. — 10% ownerPurchase (P): 7,187 @ $1.81EDGAR
2022-07-144THEUER CHARLES — President and CEO, DirectorPurchase (P): 3,000 @ $1.87 · Purchase (P): 3,000 @ $1.84EDGAR
2022-06-274Opaleye Management Inc. — 10% ownerPurchase (P): 11,419 @ $1.39EDGAR
2022-06-234Opaleye Management Inc. — 10% ownerPurchase (P): 841,989 @ $1.31EDGAR
2022-06-164Twiford J Rainer — DirectorGrant/award (A): 15,750 (derivative) @ $0EDGAR
2022-06-164Lam Carol C. — DirectorGrant/award (A): 15,750 (derivative) @ $0EDGAR
2022-06-164Johnson-Pratt Lisa — DirectorGrant/award (A): 15,750 (derivative) @ $0EDGAR
2022-06-164WORLAND STEPHEN T — DirectorGrant/award (A): 15,750 (derivative) @ $0EDGAR
2022-06-164LARUE WILLIAM R — DirectorGrant/award (A): 15,750 (derivative) @ $0EDGAR
2022-06-164MATTINGLY MARTIN A — DirectorGrant/award (A): 15,750 (derivative) @ $0EDGAR
2022-06-164PELLETIER SAUNDRA L — DirectorGrant/award (A): 15,750 (derivative) @ $0EDGAR
2022-05-114THEUER CHARLES — President and CEO, DirectorPurchase (P): 10,000 @ $1.85EDGAR

Recent 8-K events — Tracon Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-10-118-K3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-308-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-168-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-07-018-K8.01 — Other EventsEDGAR
2024-06-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-06-128-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-04-128-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-108-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TCON returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs